CanBas Co.,Ltd. 4575Short Interest
Estimated short interest in CanBas Co.,Ltd. (4575) is 4.73% of shares outstanding as of 2026-11-18. Institutions holding 0.5% or more: Barclays Capital Securities Ltd, Bronte Capital Management Pty Ltd, JPM Securities Japan Co Ltd. and 2 others.
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It excludes 2 institutions whose last report is more than a year old (1.63% in total). It also excludes 17 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2018-12-18 |
|---|---|
| Latest disclosure | 2026-11-13 (Barclays Capital Securities Ltd, 1.58%) |
| Reporting institutions | 24 firms (3585 reports) |
| Peak estimated short interest | 19.64% (2022-11-08, 6 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 5 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- Barclays Capital Securities Ltd
- Bronte Capital Management Pty Ltd
- JPM Securities Japan Co Ltd.
- GOLDMAN SACHS INTERNATIONAL
- BNP Paribas Financial Markets SNC
- Others
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2026-11-13 | Barclays Capital Securities Ltd | Position 313,900 shares | Ratio 1.58% | ▼0.05% | Holding |
| 2026-07-10 | Bronte Capital Management Pty Ltd | Position 272,200 shares | Ratio 1.38% | ▲1.38% | Holding |
| 2024-08-05 | BNP Paribas Financial Markets SNC formerly known as BNP Paribas Arbitrage SNC | Position 179,800 shares | Ratio 0.99% | ▼0.10% | No report for 1+ year |
| 2026-11-12 | JPM Securities Japan Co Ltd. | Position 136,600 shares | Ratio 0.69% | ▼0.10% | Holding |
| 2024-04-01 | Arrowstreet (Canada) Global World Alpha Extension Fund I | Position 116,700 shares | Ratio 0.64% | ▲0.13% | No report for 1+ year |
| 2026-11-09 | GOLDMAN SACHS INTERNATIONAL | Position 115,100 shares | Ratio 0.58% | ▼0.03% | Holding |
| 2026-10-07 | BNP Paribas Financial Markets SNC | Position 98,600 shares | Ratio 0.50% | ▲0.01% | Holding |
| 2022-09-15 | JANE STREET GLOBAL TRADING, LLC | Position 66,100 shares | Ratio 0.49% | ▼0.03% | Below 0.5% |
| 2025-10-28 | Arrowstreet Capital, Limited Partnership | Position 97,700 shares | Ratio 0.49% | ▼0.03% | Below 0.5% |
| 2026-09-17 | UBS AG | Position 94,700 shares | Ratio 0.48% | ▼0.05% | Below 0.5% |
| 2025-08-04 | MERRILL LYNCH INTERNATIONAL | Position 95,200 shares | Ratio 0.48% | ▼0.05% | Below 0.5% |
| 2024-03-11 | PDT Partners, LLC | Position 86,700 shares | Ratio 0.48% | ▼0.06% | Below 0.5% |
| 2026-11-11 | Morgan Stanley MUFG Securities Co., Ltd. | Position 93,800 shares | Ratio 0.47% | ▼0.10% | Below 0.5% |
| 2026-09-04 | Nomura International plc | Position 93,043 shares | Ratio 0.47% | ▼0.05% | Below 0.5% |
| 2023-11-10 | BNP Paribas Arbitrage SNC | Position 80,100 shares | Ratio 0.45% | ▼0.10% | Below 0.5% |
| 2022-03-25 | D. E. Shaw & Co. (Asia Pacific) Limited | Position 45,200 shares | Ratio 0.44% | ▼0.10% | Below 0.5% |
| 2019-11-29 | Deutsche Bank Aktiengesellschaft, London | Position 29,900 shares | Ratio 0.43% | ▼0.08% | Below 0.5% |
| 2019-12-04 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 28,100 shares | Ratio 0.41% | ▼0.13% | Below 0.5% |
| 2025-01-31 | XTX Markets Pte Ltd | Position 75,500 shares | Ratio 0.39% | ▼0.11% | Below 0.5% |
| 2024-07-18 | Arrowstreet ACWI Reduced Carbon Alpha Extension Trust Fund | Position 72,000 shares | Ratio 0.39% | ▼0.12% | Below 0.5% |
| 2019-11-22 | Credit Suisse Securities (Europe) Limited | Position 26,593 shares | Ratio 0.38% | ▼0.38% | Below 0.5% |
| 2022-10-21 | Credit Suisse AG | Position 51,200 shares | Ratio 0.34% | ▼0.35% | Below 0.5% |
| 2019-04-12 | Compass HTV LLC | Position 14,600 shares | Ratio 0.25% | ▼0.38% | Below 0.5% |
| 2019-12-03 | Credit Suisse Securities (Japan) Limited | Position 4,800 shares | Ratio 0.07% | ▼0.45% | Below 0.5% |
Disclosure History 3585 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-11-13 | Barclays Capital Securities Ltd | Position 313,900 shares | Ratio 1.58% | ▼0.05% | — |
| 2026-11-12 | JPM Securities Japan Co Ltd. | Position 136,600 shares | Ratio 0.69% | ▼0.10% | — |
| 2026-11-11 | Morgan Stanley MUFG Securities Co., Ltd. | Position 93,800 shares | Ratio 0.47% | ▼0.10% | Below 0.5% |
| 2026-11-10 | Barclays Capital Securities Ltd | Position 323,900 shares | Ratio 1.63% | ▼0.08% | — |
| 2026-11-09 | JPM Securities Japan Co Ltd. | Position 158,100 shares | Ratio 0.79% | ▼0.08% | — |
| 2026-11-09 | GOLDMAN SACHS INTERNATIONAL | Position 115,100 shares | Ratio 0.58% | ▼0.03% | — |
| 2026-11-06 | Barclays Capital Securities Ltd | Position 339,500 shares | Ratio 1.71% | ▲0.08% | — |
| 2026-11-05 | Morgan Stanley MUFG Securities Co., Ltd. | Position 113,500 shares | Ratio 0.57% | ▼0.11% | — |
| 2026-11-04 | GOLDMAN SACHS INTERNATIONAL | Position 121,300 shares | Ratio 0.61% | ▲0.05% | — |
| 2026-11-04 | Barclays Capital Securities Ltd | Position 323,600 shares | Ratio 1.63% | ▲0.11% | — |
| 2026-11-02 | Barclays Capital Securities Ltd | Position 301,500 shares | Ratio 1.52% | ▲0.04% | — |
| 2026-10-28 | JPM Securities Japan Co Ltd. | Position 172,200 shares | Ratio 0.87% | ▼0.05% | — |
| 2026-10-28 | GOLDMAN SACHS INTERNATIONAL | Position 112,000 shares | Ratio 0.56% | ▼0.04% | — |
| 2026-10-28 | Morgan Stanley MUFG Securities Co., Ltd. | Position 134,600 shares | Ratio 0.68% | ▼0.10% | — |
| 2026-10-26 | GOLDMAN SACHS INTERNATIONAL | Position 119,900 shares | Ratio 0.60% | ▲0.09% | — |
| 2026-10-26 | Morgan Stanley MUFG Securities Co., Ltd. | Position 154,300 shares | Ratio 0.78% | ▼0.10% | — |
| 2026-10-21 | Barclays Capital Securities Ltd | Position 292,643 shares | Ratio 1.48% | ▼0.10% | — |
| 2026-10-16 | JPM Securities Japan Co Ltd. | Position 182,800 shares | Ratio 0.92% | ▲0.12% | — |
| 2026-10-16 | Morgan Stanley MUFG Securities Co., Ltd. | Position 175,100 shares | Ratio 0.88% | ▼0.10% | — |
| 2026-10-09 | Barclays Capital Securities Ltd | Position 311,643 shares | Ratio 1.58% | ▼0.02% | — |
| 2026-10-08 | Barclays Capital Securities Ltd | Position 316,443 shares | Ratio 1.60% | ▲0.06% | — |
| 2026-10-07 | BNP Paribas Financial Markets SNC | Position 98,600 shares | Ratio 0.50% | ▲0.01% | — |
| 2026-10-05 | BNP Paribas Financial Markets SNC | Position 98,400 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2026-10-05 | Morgan Stanley MUFG Securities Co., Ltd. | Position 193,200 shares | Ratio 0.98% | ▼0.02% | — |
| 2026-10-01 | JPM Securities Japan Co Ltd. | Position 158,800 shares | Ratio 0.80% | ▲0.10% | — |
| 2026-10-01 | Morgan Stanley MUFG Securities Co., Ltd. | Position 198,000 shares | Ratio 1.00% | ▲0.02% | — |
| 2026-09-30 | Morgan Stanley MUFG Securities Co., Ltd. | Position 193,900 shares | Ratio 0.98% | ▼0.09% | — |
| 2026-09-28 | JPM Securities Japan Co Ltd. | Position 139,600 shares | Ratio 0.70% | ▲0.08% | — |
| 2026-09-25 | GOLDMAN SACHS INTERNATIONAL | Position 101,800 shares | Ratio 0.51% | ▲0.11% | — |
| 2026-09-17 | UBS AG | Position 94,700 shares | Ratio 0.48% | ▼0.05% | Below 0.5% |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| KYORIN Pharmaceutical Co.,Ltd.4569 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |
| Immuno-Biological Laboratories Co.,Ltd.4570 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Nano Holdings,Inc.4571 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Carna Biosciences,Inc.4572 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| TAIKO PHARMACEUTICAL CO.,LTD.4574 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 2 |
| D.Western Therapeutics Institute, Inc.4576 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Daito Pharmaceutical Co.,Ltd.4577 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 2 |
| Otsuka Holdings Co.,Ltd.4578 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Large70 |
| RaQualia Pharma Inc.4579 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| SymBio Pharmaceuticals Limited4582 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical |